Evidence map›Paper›PMID 29507585›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

The Anti-Inflammatory Effect of Fructus Kochiae on Allergic Contact Dermatitis Rats via pERK1/2/TLR4/NF-

Zuoqi Xiao, Suxi Xiao, Yongning Zhang, Tao Pan, Bo Ouyang

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  6. Article
  7. Kochiae Fructus, the Fruit of Common PotherbEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zuoqi XiaoHunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, China.ORCID 0000-0001-8619-0674
Suxi XiaoCollege of Biomedical Engineering, South-Central University for Nationalities, Wuhan 430074, China.ORCID 0000-0002-7912-3665
Yongning ZhangCollege of Biomedical Engineering, South-Central University for Nationalities, Wuhan 430074, China.ORCID 0000-0001-5473-8033
Tao PanHunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, China.ORCID 0000-0002-9339-2239
Bo OuyangHunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, China.ORCID 0000-0003-2153-7803
Hunan Provincial Maternal and Child Health Hospital · CNSouth Central Minzu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic contact dermatitis (ACD) is a common irritability skin disease, which can be cured by using the Chinese patent medicine. To explore the pharmacological effect of total flavonoids of Fructus Kochiae (FK) on ACD, we used dinitrochlorobenzene- (DNCB-) induced ACD rats. Five groups were used in our experiments. The normal group and the DNCB group were treated with 0.5% CMC-Na; the DNCB + hFK group was treated with a high dose of total flavonoids of FK (200 mg/kg); the DNCB + lFK group was treated with a low dose of FK (100 mg/kg); the DNCB + Pre group was treated with prednisolone acetate (2.5 mg/kg). The results showed that FK treatment had significantly attenuated the inflammation induced by DNCB. The increased concentration of cytokines including IL-6, IL-18, and IFN-

Identifiers

PMID29507585
PMCPMC5817368
OpenAlexW2781556664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.